{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkJTnsbQJDA","lastupdate":"2024-02-05T00:00:00.000Z","update_date":"2024-02-05T00:00:00.000Z","lastModified":"Dec 19, 2024","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"edity-therapeutics","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$YWxdIs27YnDreevM2fsBWfcfv4lcu4veeEpChudHuAKeAYyfpl20DC.png","name":"Edity Therapeutics","oneliner":"Using Human Immune Cells to Deliver Therapeutic Proteins","registrar":"516095270","website":"https://edity-tx.com","careerspage":"","founded_month":10,"founded_year":2019,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/@editytherapeuticsltd.388","facebook":"","linkedin":"https://www.linkedin.com/company/67330457","instagram":""},"social":["https://www.linkedin.com/company/67330457","https://www.youtube.com/@editytherapeuticsltd.388"],"flattenedsociallinks":"https://www.linkedin.com/company/67330457|https://www.youtube.com/@editytherapeuticsltd.388","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":20,"patent":1,"raised":13632300,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Edity","editherapeutics"],"about":"Edity is developing an exciting new platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to reprogram cells and tissue back to health.\n\nThe technology creates the opportunity to change the course of disease at the intracellular level via multiple mechanisms including protein replacement, target modulation, genetic correction and protein gain of function.  Currently, the company is working across a number of indications, including oncology and genetic disease, while developing programs for regeneration and longevity.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972547414417","country":null,"address":{"israeli":[{"id":"SdyXrkNZ02Of90rSj5y1yfXJWVkfvhHp7HOlCcVtzO8jmFPzideOVo","city":"Rehovot","type":null,"address":"Prof. Menakhem Plaut St, Rehovot, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[{"id":"aKsXWxIbC1e6cFlsoXR1IKn9fv6PARJGXQiprKgGUux6ar23TdUYKA","date":"Jan 16, 2024","link":"https://www.webwire.com/ViewPressRel.asp?aId=316507","source":"www.webwire.com","visible":1,"analysis":{"tags":"Partnership, Investment","company":"Edity Therapeutics","layoffs":"Not mentioned","summary":"Edity Therapeutics has announced a strategic collaboration with Dr. Reddys Laboratories Ltd. to create novel cell therapy medicines using Editys proprietary delivery platform. As part of the agreement, Dr. Reddys will provide CDMO services to support Editys clinical development and cell therapy manufacturing activities. This follows Dr. Reddys previous acquisition of an equity stake in Edity. The collaboration aims to address the challenges of cell therapies in solid tumors, including antigen heterogeneity, the immunosuppressive tumor microenvironment, and tumor resistance to death.","partners":"Dr. Reddys Laboratories Ltd.","customers":"Not mentioned","investors":"Dr. Reddys Laboratories Ltd.","confidence":9,"key_topics":["Strategic Collaboration","Cell Therapy","Oncology","Equity Stake","CDMO Services"],"date_of_event":"Tuesday, January 16, 2024","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Investment"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZUzr6U05ioH6W9Oog3rR0tAFb4R4uYAzJz5DKYc8HpNfNWps4HiqYK","news_summary":"Edity Therapeutics enters into a Strategic Collaboration with Dr. Reddy's Laboratories to Advance Novel Cell Therapy Approach Using Edity's Proprietary Delivery Platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":1,"techcommunityinvolvement":null,"mediagallery":[{"id":"xmZe3pbPmvWmMbIs6u9UwpCmM0HvRBld0NjpH4YBB8tqa1a8rtgXBO","timestamp":"2023-02-12 10:23:10.000000","resources_type":2,"resources_title":"","resources_file_name":"vaU_PALZh2I","alt":"","imageurl":"https://img.youtube.com/vi/vaU_PALZh2I/0.jpg","url":"http://youtu.be/vaU_PALZh2I"}],"tags":["drug-delivery","proteins","gene-editing","biotechnology","genetics","genomics","genetic-disorders","oncology"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[{"id":"0EExzduZag3XTDuCkFEPl3sf1kY5SiwsAoPBLcnE3yyz9GnTJjDkX6","link":"https://edity-tx.com/wp-content/uploads/2022/11/Triggering-immune-response-from-within-cancer-cells-poster-2.pdf","name":"Triggering immune response from within cancer cells Abstract","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T18:19:47.442Z","Revenue Growth":5,"Risk Mitigation":4,"Industry Vertical":"Biotechnology","ready_for_display":false,"Talent Development":3,"Agility & Innovation":5,"Customer Acquisition":5,"Operational Efficiency":1,"Short Solution Description":"Edity Therapeutics is developing a novel CRISPR-based gene editing therapy delivered via lipid nanoparticles to introduce synthetic neoantigens directly into cancer cells, aiming to turn 'cold' tumors 'hot' and make them susceptible to immune attack."}}],"businessmodels":["B2B"],"productstage":"R&D","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":7,"lastfunding":"$11.1M","totalrounds":3,"fundingstage":"A","totalfunding":"$13.63M","publicinvestors":7,"lastpublicfunding":11100000,"totalpublicrounds":3,"totalpublicfunding":13632300},"team":[{"name":"Eyal Kolka","email":"eyal@edity-tx.com","phone":"","gender":"Male","userid":"fMXsQLlaxyIBMwlNp1CU8JFHg033V5O7AGAYGcEvKXgUBqnUdJwxGz","bounced":true,"claimed":null,"founder":1,"urlname":"eyal-kolka-2","visible":1,"memberid":"FMD45aYeKzjqtPM7An0ZFnYsRclwu2IUeppjM9zISYBIy2QnkPhGXv","position":"Co-founder & Chairman of Board","last_name":"Kolka","claimtoken":"IZ4fxMoW5C2PnocD3tuZ9dY5ySbJ80dJL45JLV1hgTE6L9ojiH71Oi","first_name":"Eyal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eyal-kolka-b3a3a6/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-02-05 13:02:18.000000","initials":"EK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Michal Golan Mashiach","email":"michal@edity-tx.com","phone":"","gender":"Female","userid":"VPJAXT98liOIxJygLw8TKEqSrAKCRN9bN8oFd2V5cvf5C8AoszVpI7","bounced":false,"claimed":null,"founder":1,"urlname":"michal-golan","visible":1,"memberid":"S0qTEKiqkp2js4yNPeh9SMnem6oS6pwF4JDmLl4Z33Le15mYRR6FbD","position":"Co-founder & CEO","last_name":"Golan Mashiach","claimtoken":"ERDSXpO9DGx7A0yTk4Rm9opH5RNj8lyv4R6oFZw9vwP5UL9HKr4VhQ","first_name":"Michal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/michalgolanmashiach/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-02-05 13:02:22.000000","initials":"MG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yoav Manaster","email":"yoav@edity-tx.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkPSA8f0IDA","bounced":false,"claimed":0,"founder":1,"urlname":"yoav-manaster","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ1Pie2ggM","position":"Co-founder","last_name":"Manaster","claimtoken":"u3KljlgQglP4aivKWrEaVbPf4ThMKSYWIihKxmjXziWGDpAfIee2j1","first_name":"Yoav","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yoav-manaster-2b7ab125/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-02-12 10:25:38.000000","initials":"YM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkNi044UKDA","fullname":"Matan Eblagon"},"biverifydate":"2022-04-11T00:00:00.000Z","crunchbaseid":"edity-therapeutics","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2022-03-17T00:00:00.000Z","biverification":"Matan Eblagon","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"7QSFmdd4hvFmgcvO8nMKc4OPkiThaxprK4wwM1msJ6QkvgnI0twsBp","date":"Dec 2023","amount":"$11.1M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"Dr. Reddy's Laboratories","type":"Multinational","amount":null,"hidden":true,"country":"India","fullurl":"/mnc_page/dr-reddys-laboratories","logokey":"$3Ax5jBtYLsVkTyxohGz7AiibuT62v36PNWOYCM3K2dI3krpZMjnJKw.png","tagline":"Generic drug manufacturer","urlname":"/mnc_page/dr-reddys-laboratories","isisraeli":0,"investorid":"D5ySRc3PflfKqMFuxYiLwYoi4g305rd0ysoO9L4z6oc813c5qaGCWx","fundingtype":"Multinational","leadpartner":null,"investmentid":"vWJh0myWPyuvKcL6W3UngUQv1hzqBFGHi9sg72Gjzvoi0DxtfWxVeI","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Ax5jBtYLsVkTyxohGz7AiibuT62v36PNWOYCM3K2dI3krpZMjnJKw.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":11100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"IRHW1BcggsbFVak062ZkKwZ5obCYWz8VpPvLbz9kDHqgxGbJBu4yOV","date":"Oct 2023","amount":"$252.3K","source":"https://www.ourcrowd.com/myportfolio/opportunities/edity-therapeutics?utm_campaign=OurCrowd%20Weekly%20Newsletter&utm_medium=email&utm_content=290818965&utm_source=hs_email","eventtype":"FundingRoundEvent","investment":[{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5kBvmxDTSgxbF5CPe8QXvAOac2zYYxeoRqAoBqRX8hRmeXIXy6Tfb8","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"","followupcaption":""},{"name":"Loop Ventures","type":"Investor","amount":null,"hidden":false,"country":"Spain","fullurl":"/investor_page/loop-ventures","logokey":null,"tagline":null,"urlname":"/investor_page/loop-ventures","isisraeli":0,"investorid":"weXmd12AjaC7rLHNM6ruRYTHRrgKvb4sSQOMnpu7V4xB26V0ExCnx8","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6jGpt2hNR1LkRMorGZS63CkZ2R0vodIVXrX9hLUiQhwP0xDymkBXy0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Reinforced Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/reinforced-ventures","logokey":null,"tagline":null,"urlname":"/investor_page/reinforced-ventures","isisraeli":0,"investorid":"B930OkHurt8fQhOV9eVzryAmWHFzlrHZxcmZ9REFMgrrXgbVduqZMo","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ILANTYB5u3aoZ3pmGbJOSIkALZE5vsQx24NGx3YMipT6Jl4hHVM8DC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Gaingels","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/gaingels","logokey":"$maW9obCAkQErUeDEPCTsJaRjKqXCwebJcuQ3GIqrFoKTuV2Ne3txb7","tagline":"","urlname":"/investor_page/gaingels","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCgjYqQCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"pfM09wkI8LsNLAmudEPnrENwJ8f3CH1y0CjyfFfPmVkVXzR6rptbay","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$maW9obCAkQErUeDEPCTsJaRjKqXCwebJcuQ3GIqrFoKTuV2Ne3txb7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":252300,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJD0ueuyCAw","date":"Sep 2021","amount":"$2.28M","source":"https://tal-ventures.com/portfolio/, https://www.linkedin.com/in/omri-amirav-drory-50572727/details/experience/, https://www.linkedin.com/in/roy-oron-420439155/details/experience/https://www.linkedin.com/in/roy-oron-420439155/details/experience/","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Igybr0utAE8UjiAXwedrT00B4AUgX5L6AcjswgHjQxhql3fAmRDhpi","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"","followupcaption":""},{"name":"Tal Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eS6PKo4crYn4LOof5gUnJI43VkOwK3PjhGyjvJhcCWgocolb0itjSB","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2280000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/2019","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Edity Therapeutics","logourl":"https://storage.googleapis.com/clean-finder-353810/$YWxdIs27YnDreevM2fsBWfcfv4lcu4veeEpChudHuAKeAYyfpl20DC.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$YWxdIs27YnDreevM2fsBWfcfv4lcu4veeEpChudHuAKeAYyfpl20DC.png","seoabout":"Edity is developing an exciting new platform that harnesses the immune system to deliver therapeutic proteins direct to the cytoplasm of target cells to re...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Biotechnology","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Genes","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Genes"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Genes"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"7QSFmdd4hvFmgcvO8nMKc4OPkiThaxprK4wwM1msJ6QkvgnI0twsBp","date":"Dec 2023","amount":"$11.1M","source":"","eventtype":"FundingRoundEvent","investment":[{"name":"Dr. Reddy's Laboratories","type":"Multinational","amount":null,"hidden":true,"country":"India","fullurl":"/mnc_page/dr-reddys-laboratories","logokey":"$3Ax5jBtYLsVkTyxohGz7AiibuT62v36PNWOYCM3K2dI3krpZMjnJKw.png","tagline":"Generic drug manufacturer","urlname":"/mnc_page/dr-reddys-laboratories","isisraeli":0,"investorid":"D5ySRc3PflfKqMFuxYiLwYoi4g305rd0ysoO9L4z6oc813c5qaGCWx","fundingtype":"Multinational","leadpartner":null,"investmentid":"vWJh0myWPyuvKcL6W3UngUQv1hzqBFGHi9sg72Gjzvoi0DxtfWxVeI","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Ax5jBtYLsVkTyxohGz7AiibuT62v36PNWOYCM3K2dI3krpZMjnJKw.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":11100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"IRHW1BcggsbFVak062ZkKwZ5obCYWz8VpPvLbz9kDHqgxGbJBu4yOV","date":"Oct 2023","amount":"$252.3K","source":"https://www.ourcrowd.com/myportfolio/opportunities/edity-therapeutics?utm_campaign=OurCrowd%20Weekly%20Newsletter&utm_medium=email&utm_content=290818965&utm_source=hs_email","eventtype":"FundingRoundEvent","investment":[{"name":"OurCrowd","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/ourcrowd","logokey":"$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","tagline":null,"urlname":"/investor_page/ourcrowd","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7H-oQKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5kBvmxDTSgxbF5CPe8QXvAOac2zYYxeoRqAoBqRX8hRmeXIXy6Tfb8","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7IbHrXXd8dSbWrifZtvAYNCvwQvEjxCgGJeOg7DXKENs3TbpV3W9g1","leadcaption":"","followupcaption":""},{"name":"Loop Ventures","type":"Investor","amount":null,"hidden":false,"country":"Spain","fullurl":"/investor_page/loop-ventures","logokey":null,"tagline":null,"urlname":"/investor_page/loop-ventures","isisraeli":0,"investorid":"weXmd12AjaC7rLHNM6ruRYTHRrgKvb4sSQOMnpu7V4xB26V0ExCnx8","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6jGpt2hNR1LkRMorGZS63CkZ2R0vodIVXrX9hLUiQhwP0xDymkBXy0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Reinforced Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/reinforced-ventures","logokey":null,"tagline":null,"urlname":"/investor_page/reinforced-ventures","isisraeli":0,"investorid":"B930OkHurt8fQhOV9eVzryAmWHFzlrHZxcmZ9REFMgrrXgbVduqZMo","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ILANTYB5u3aoZ3pmGbJOSIkALZE5vsQx24NGx3YMipT6Jl4hHVM8DC","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Gaingels","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/gaingels","logokey":"$maW9obCAkQErUeDEPCTsJaRjKqXCwebJcuQ3GIqrFoKTuV2Ne3txb7","tagline":"","urlname":"/investor_page/gaingels","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCgjYqQCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"pfM09wkI8LsNLAmudEPnrENwJ8f3CH1y0CjyfFfPmVkVXzR6rptbay","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$maW9obCAkQErUeDEPCTsJaRjKqXCwebJcuQ3GIqrFoKTuV2Ne3txb7","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Equity crowdfunding","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":252300,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJD0ueuyCAw","date":"Sep 2021","amount":"$2.28M","source":"https://tal-ventures.com/portfolio/, https://www.linkedin.com/in/omri-amirav-drory-50572727/details/experience/, https://www.linkedin.com/in/roy-oron-420439155/details/experience/https://www.linkedin.com/in/roy-oron-420439155/details/experience/","eventtype":"FundingRoundEvent","investment":[{"name":"NFX Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/nfx-guild1","logokey":"$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","tagline":null,"urlname":"/investor_page/nfx-guild1","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KTEh9IIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Igybr0utAE8UjiAXwedrT00B4AUgX5L6AcjswgHjQxhql3fAmRDhpi","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wyFW415Hl7g4xa3CX4uzm5VjA6wcovghFNMwaB46FtfD9vlqyR2iuC","leadcaption":"","followupcaption":""},{"name":"Tal Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/tal-capital","logokey":"$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","tagline":null,"urlname":"/investor_page/tal-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PGjr50KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"eS6PKo4crYn4LOof5gUnJI43VkOwK3PjhGyjvJhcCWgocolb0itjSB","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$14amJausY0Agqsfwm9AbA25Dy9UCXStytKXB5cjED3v4XZm0pmAP6u","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2280000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}